Guangzhou Baiy reported CNY89.76B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Aspen Pharmacare ZAR 128.05B 7.85B Dec/2025
Cipla INR 424.96B 23.32B Mar/2026
Dr.Reddys Laboratories INR 581.23B 18.34B Mar/2026
Jiangsu Hengrui CNY 71.29B 1.43B Mar/2026
Kalbe Farma IDR 30.1T 593.01B Sep/2025
Richter Gedeon HUF 1.76T 79.96B Mar/2026
Sh Fosun Pharma CNY 122.97B 2.91B Mar/2026
Sh Pharmaceutical CNY 233.15B 3.6B Dec/2025
Sun Pharmaceuticals INR 1.09T 50.79B Mar/2026
Teva Pharmaceutical Industries USD 40.04B 708M Mar/2026